</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3004.49.00.70/Thebaine-Derived Buprenorphine 2mg Sublingual Tablets/Canada

Thebaine-Derived Buprenorphine 2mg Sublingual Tablets from Canada

Sublingual tablets of buprenorphine, derived from thebaine alkaloid, used for opioid addiction treatment in measured doses. Fits HTS 3004.49.0060 as alkaloid-derivative medicament put up for retail therapeutic use.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Require DEA waiver for opioid addiction treatment imports

• Document REMS program participation for entry clearance

Thebaine-Derived Buprenorphine 2mg Sublingual Tablets from Canada — Import Duty Rate | HTS 3004.49.00.70